登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Dataset of the trial MALVA (Meet-URO 25a)
Dataset of the trial MALVA (Meet-URO 25a)
收藏
Zenodo
2024-08-21 更新
2026-04-07 收录
数据链接：
https://zenodo.org/doi/10.5281/zenodo.13353245
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Dataset of the trial MALVA (Meet-URO 25a)
应用场景：
提供机构：
Istituto Oncologico Veneto IOV IRCCS
创建时间：
2024-08-21
相关数据集
Dataset related to the paper "Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy"
肿瘤免疫治疗预后预测
炎症生物标志物
Dataset related to the paper "Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy"
Zenodo
2023-11-06 更新
1
0
Dataset for the ARON-1 trial, paper "Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell CarcinomaTreated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from theARON-1 Retrospective Study)"
非透明细胞肾细胞癌治疗
真实世界数据分析
Dataset for the ARON-1 trial
Zenodo
2024-08-21 更新
0
0
Dataset for the ARON-2 trial, paper Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-basedchemotherapy: the ARON-2 study.
尿路上皮癌
肿瘤免疫治疗真实世界研究
Dataset for the ARON-2 trial, paper: Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-basedchemotherapy: the ARON-2 study.
Zenodo
2024-08-21 更新
0
0
dataset for paper: Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab
肾细胞癌免疫治疗预后
钠水平与临床结局
dataset for paper: Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab
Zenodo
2024-08-21 更新
0
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
